Compare JAZZ & AIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JAZZ | AIZ |
|---|---|---|
| Founded | 2003 | 1892 |
| Country | Ireland | United States |
| Employees | N/A | 14800 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 13.9B |
| IPO Year | 2007 | N/A |
| Metric | JAZZ | AIZ |
|---|---|---|
| Price | $248.75 | $279.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | $217.57 | ★ $256.83 |
| AVG Volume (30 Days) | ★ 789.8K | 310.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.43 | N/A |
| Revenue | ★ $1,618,693,000.00 | N/A |
| Revenue This Year | $6.22 | $7.39 |
| Revenue Next Year | $7.68 | $5.52 |
| P/E Ratio | $54.80 | ★ $12.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $105.00 | $183.39 |
| 52 Week High | $250.49 | $284.12 |
| Indicator | JAZZ | AIZ |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 66.84 |
| Support Level | $222.49 | $230.25 |
| Resistance Level | $250.49 | $284.12 |
| Average True Range (ATR) | 7.32 | 5.27 |
| MACD | 0.01 | -0.55 |
| Stochastic Oscillator | 89.13 | 79.89 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions, consumer electronics and appliances services, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. In addition, the Company reports the Corporate and Other segment, which includes corporate employee-related expenses, activities of the holding company and investments in the home warranty business.